Review
Open access
Aug 2026
Advancing Type 1 Diabetes Treatment: 3 PM‐Oriented Innovations in Islet Transplantation and Biomaterial Engineering
Advances in islet transplantation and regenerative biomaterial engineering are highlighted as key enablers of the transition from reactive treatment to 3 PM‐guided, patient‐tailored therapy for T1D.
Fatemeh Sabet Sarvestani, R. Yaghobi, Mohsen Khosravi-Maharlooei et al.
· Diabetes/Metabolism Research... · 0 citations